全文获取类型
收费全文 | 1697篇 |
免费 | 66篇 |
国内免费 | 83篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 83篇 |
妇产科学 | 12篇 |
基础医学 | 178篇 |
口腔科学 | 32篇 |
临床医学 | 263篇 |
内科学 | 338篇 |
皮肤病学 | 34篇 |
神经病学 | 87篇 |
特种医学 | 331篇 |
外科学 | 202篇 |
综合类 | 28篇 |
预防医学 | 60篇 |
眼科学 | 8篇 |
药学 | 110篇 |
肿瘤学 | 75篇 |
出版年
2022年 | 7篇 |
2021年 | 15篇 |
2020年 | 3篇 |
2019年 | 14篇 |
2018年 | 9篇 |
2017年 | 16篇 |
2016年 | 14篇 |
2015年 | 23篇 |
2014年 | 15篇 |
2013年 | 41篇 |
2012年 | 26篇 |
2011年 | 31篇 |
2010年 | 58篇 |
2009年 | 53篇 |
2008年 | 37篇 |
2007年 | 73篇 |
2006年 | 32篇 |
2005年 | 41篇 |
2004年 | 33篇 |
2003年 | 27篇 |
2002年 | 33篇 |
2001年 | 49篇 |
2000年 | 49篇 |
1999年 | 41篇 |
1998年 | 103篇 |
1997年 | 89篇 |
1996年 | 115篇 |
1995年 | 87篇 |
1994年 | 92篇 |
1993年 | 76篇 |
1992年 | 40篇 |
1991年 | 43篇 |
1990年 | 46篇 |
1989年 | 42篇 |
1988年 | 54篇 |
1987年 | 35篇 |
1986年 | 37篇 |
1985年 | 39篇 |
1984年 | 22篇 |
1983年 | 28篇 |
1982年 | 25篇 |
1981年 | 25篇 |
1980年 | 23篇 |
1979年 | 10篇 |
1978年 | 17篇 |
1977年 | 14篇 |
1976年 | 14篇 |
1975年 | 17篇 |
1974年 | 2篇 |
1971年 | 5篇 |
排序方式: 共有1846条查询结果,搜索用时 15 毫秒
1.
2.
3.
H. Isoniemi J. Ahonen B. Eklund K. Höckerstedt K. Salmela E. von Willebrand P. Häyry 《Transplant international》1990,3(2):92-97
We have investigated the impact of triple drug immunosuppression on the occurrence of early inflammatory episodes, as detected by fine needle aspiration biopsy, and of episodes of clinical rejection during the immediate postoperative period. The prospective component of this study includes 128 consecutive first cadaveric renal transplant recipients receiving triple drug treatment consisting of azathioprine (Aza), cyclosporin (CyA) and methylprednisolone (MP). For controls we have used three historical groups: one immunosuppressed with Aza and MP (group A), another with CyA monotherapy (group B), and the third with CyA together with MP (group C) in equivalent drug dosages. On the average, 0.8 episodes of inflammation per patient were recorded during the immediate postoperative period of 30 days with triple drug treatment. This was significantly less than the 1.3 episodes in patients receiving Aza and MP (P<0.01), the 1.7 episodes in patients on CyA monotherapy (P<0.001), or the 1.6 episodes in patients receiving CyA together with MP (P<0.001). Although the first episode of inflammation commenced concurrently in each group and the peak intensity of inflammation was the same, the mean duration of inflammation was significantly shorter-2.7 days-under triple drug treatment than the 7.8–11.7 days for controls (P<0.001). The frequency of rejection episodes under triple treatment was also significantly lower-0.2 per patient-than the 0.8 per patient in controls (P<0.001). The first rejection episode occurred later in the triple drug treatment group-on the average, on day 15.2-than in the historical controls (on days 7.7–11.7). There was, however, no difference in the duration of rejection. There were no differences in patient survival between the four groups. Graft survival was 97% at 10 weeks for triple drug-treated recipients and 79%, 68%, and 87% for first grafts in groups A, B, and C, respectively. Disregarding a minor demographic bias for the triple drugtreated group with respect to preformed antibodies and preoperative dialysis treatment, the study suggests that the triple drug protocol, in the short run, is superior to any conceivable double drug combination or CyA monotherapy. 相似文献
4.
5.
The urinary excretion of the n-hexane metabolite 2,5-hexanedione (HD) was determined in four shoe factory workers during four workingdays that were preceded by four free days and followed by two free days. The correlation between excretion of HD and the n-hexane concentrations in the workroom air was evaluated. The air concentrations of n-hexane and those of acetone, toluene, and other organic solvents were monitored with charcoal tubes. All the urine from each worker was collected at freely chosen intervals during the experimental period and the following two free days. The samples were analysed by gas chromatography. The relative excretion of HD increased as the exposure to n-hexane increased, although it seemed that HD accumulated progressively in the body at the highest n-hexane concentrations and at higher total solvent concentrations. 相似文献
6.
7.
8.
9.
10.
H. Isoniemi J. Ahonen B. Eklund K. Höckerstedt K. Salmela E. von Willebrand P. Häyry 《Transplant international》1990,3(1):121-127
Abstract. A prospective randomized study was conducted to evaluate the impact of four different conversion protocols on graft outcome in long-term follow-up. Between January 1986 and May 1987, 128 patients with first cadaveric kidney allografts were randomized at the time of transplantation to four treatment groups of 32 patients each, to be assigned 10 weeks post-transplantation. During the first 10 weeks, all patients received triple therapy with low-dose azathioprine (Aza), cyclosporin (CyA), and methylprednisolone (MP). After 10 weeks, one group continued with triple therapy (group A) while the three other groups received different combinations of two drugs, namely, Aza and CyA (group B), Aza and MP (group C), or CyA and MP (group D). Withdrawal of MP (group B) or especially of CyA (group C) was associated with 4/29 (14%) and 10/28 (36%) acute rejection episodes, respectively, for 60 days after conversion. All rejections were mild and reversible. There were no rejections after Aza withdrawal or in the group that continued on triple therapy during the corresponding time period. The most common reason for dropping out after withdrawal, for those patients who could not continue on the originally randomized medication, was azathioprine intolerance (n= 12). Five patients were switched back to triple therapy after CyA withdrawal due to rejection. Steroid intolerance was rare and CyA in low doses was very well tolerated. At 1 year there were no statistically significant differences in graft survival between groups A, B, C, and D-81 %, 88%, 88%, and 88%, respectively-or in patient survival-88%, 88%, 88%, and 97%, respectively. For those patients continuing with the originally randomized treatment protocol, there were no differences in patient or graft survival either, the means being 91% and 89%, respectively. The most common cause of death after withdrawal was cardiovascular in nature, and there were no more fatal infections under triple drug treatment than with double drug regimens. There were no statistically significant differences in mean serum creatinine values at 1 year. The median serum creatinine values for groups A, B, C, and D were 112, 132, 133, and 133 μmol/l, respectively. At 1 year the mean CyA dose in the groups that continued with CyA was 3. 5–4. 2 mg/kg per day and CyA concentrations were equal. 相似文献